Oct 18, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, Oct. 18, 2017 -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce that the City of Edmonton has granted Alberta Green Biotech, a subsidiary of the...
Oct 18, 2017 12:01 pm UTC| Business
EL SEGUNDO, Calif., Oct. 18, 2017 -- Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ:LMRK) announced today that the board of directors of its general partner declared a cash distribution of $0.3575 per...
Benevity Delivers the Industry’s Most Inclusive Corporate Giving and Volunteering Solution
Oct 18, 2017 12:01 pm UTC| Business
CALGARY, Alberta, Oct. 18, 2017 -- Benevity, Inc., the global leader in workplace giving, volunteering and community investment software, announced today that its award-winning enterprise solution, Spark, now meets WCAG...
Oct 18, 2017 12:01 pm UTC| Business
BETHESDA, Md., Oct. 18, 2017 -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model, showing that at...
Plus Receives $2M Series A for Cannabis-Infused Products
Oct 18, 2017 12:01 pm UTC| Business
PALO ALTO, Calif., Oct. 18, 2017 -- Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing (the “Financing”). The Financing was comprised of $2 Million USD of...
FDA Advisory Committee Scheduled to Review TLANDO™ on January 10, 2018
Oct 18, 2017 12:01 pm UTC| Business
SALT LAKE CITY, Oct. 18, 2017 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (“FDA”) has scheduled the Bone, Reproductive and Urologic Drugs...
Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
Oct 18, 2017 12:01 pm UTC| Business
SAN DIEGO, Oct. 18, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its third quarter...